Pharmint

23/04/2025

India’s Rise as a Global CMO Powerhouse: How Pharmint Connects the World to Trusted Pharma Manufacturing

In today’s fast-evolving global pharmaceutical landscape, Contract Manufacturing Organizations (CMOs) have become essential partners for pharma companies, startups, and even government health departments worldwide. By outsourcing manufacturing to CMOs, businesses can focus on innovation, R&D, and market expansion while ensuring cost-efficient, high-quality, and compliant production.

Among all players, India has emerged as a global leader in contract pharmaceutical manufacturing, offering WHO-GMP, US FDA, EU-GMP, and ISO-compliant manufacturing capabilities at highly competitive costs. From generic drugs and nutraceuticals to oncology, dermatology, and ayurvedic formulations, India’s CMOs are powering pharmaceutical supply chains across Africa, Southeast Asia, Latin America, and the Middle East.

https://pharmint.net/indias-rise-as-a-global-cmo-powerhouse-how-pharmint-connects-the-world-to-trusted-pharma-manufacturing/

22/04/2025

Global Surge in Dermatology Product Demand: What Cross-Border Buyers Must Know

In the last decade, dermatology has emerged as one of the fastest-growing sectors in the global pharmaceutical market. With rising awareness about skin health, increasing incidence of dermatological conditions, and growing interest in cosmeceuticals, the demand for dermatology products is surging across continents—particularly in Africa, the Middle East, and Latin America.

For global B2B pharmaceutical buyers, this presents a massive opportunity. But navigating cross-border pharma trade in this segment requires deep understanding of product quality, regulatory standards, and reliable sourcing.

Riding the Wave of Skin Health: Insights for Global Pharma Trade

18/04/2025

The Role of COA, MSDS, and Regulatory Certificates in Ensuring Quality Assurance in Cross-Border Pharma Trade-

In the global B2B cross-border pharmaceutical trade, quality assurance is not just an added benefit—it’s a non-negotiable standard. Whether you’re sourcing generic pharmaceuticals, active pharmaceutical ingredients (APIs), OTC drugs, or formulations, ensuring the credibility and compliance of every shipment is critical.

That’s where documents like COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and Regulatory Certificates become vital. These certifications are the backbone of pharma quality control and act as trust-building tools between pharma exporters and international pharmaceutical companies.

In the global B2B cross-border pharmaceutical trade, quality assurance is not just an added benefit—it’s a non-negotiable standard. Whether you're sourcing

15/04/2025

Ayurveda Goes Global: Rising Demand & Cross-Border Opportunities for Herbal Medicines

In a rapidly evolving global healthcare landscape, Ayurvedic medicines—once seen as a traditional or regional practice—are now making strong inroads into international pharmaceutical markets. As more countries embrace natural and holistic health solutions, the cross-border pharma trade of Ayurvedic formulations has seen a dramatic surge.

At the heart of this evolution, platforms like Pharmint are playing a vital role in connecting global pharma buyers with verified Ayurvedic manufacturers from India, offering quality assurance, transparent pricing, and regulatory support.

In a rapidly evolving global healthcare landscape, Ayurvedic medicines—once seen as a traditional or regional practice—are now making strong inroads into

15/04/2025

How Artificial Intelligence is Disrupting Pharma. AI/ML Biopharma Megadeals Hit Nearly $10B in 2024

Here’s how it played out:

🔹 Eli Lilly and Novartis took the lead, each securing three major deals.
🔹 Bristol Myers Squibb, Takeda, Merck Group, GSK, and Roche emerged as key players in AI/ML integration.
🔹 Isomorphic Labs stole the spotlight with two billion-dollar-plus deals—teaming up with both Lilly and Novartis.

Why start from scratch when you can plug in best-in-class platforms—from antibody engineering to molecular glues—right into your pipeline?

Top AI-Driven Deals to Watch:
💲 Dyno Therapeutics x Roche – $1.05B
💲 Generate:Biomedicines x Novartis – $1.07B
💲 Ochre Bio x Boehringer Ingelheim – $1.04B
💲 Isomorphic Labs x Eli Lilly – $1.75B

As AI cements its place as the new standard in biopharma R&D, the real winners will be those who scale with agility—acquiring, adapting, and accelerating innovation across every step of the value chain.

Credit: Maryam Daneshpour
Source: IQVIA Pharma Deals, Jan 2025

12/04/2025

The cost of insulin varies significantly across countries, with the United States exhibiting notably higher prices compared to other nations. According to a study by the RAND Corporation, the average price per vial of insulin in the U.S. was approximately $99 in 2018, which is substantially higher than in other countries. ​

In contrast, other countries report much lower insulin prices. For example, Chile and Mexico have average prices of $21 and $16 per vial, respectively. Many nations, including Canada, Germany, and Japan, have insulin prices ranging between $10 to $14 per vial. Notably, Turkey offers insulin at approximately $3 per vial, making it one of the most affordable globally. ​

These disparities highlight the significant differences in insulin affordability worldwide, underscoring the challenges faced by individuals in countries with higher prices.

10/04/2025

Marine Pharma: The next frontier in global pharmaceutical trade

As the pharmaceutical industry evolves to meet the increasing demand for innovative therapies, one of the most exciting and lesser-known frontiers is marine pharmaceuticals—a growing segment that is gaining attention in global pharma trade.

From anticancer agents to antimicrobial compounds, the oceans are proving to be a rich source of bioactive molecules. For players in the B2B pharma trade, especially those sourcing through cross-border pharmaceutical platforms like Pharmint, this presents a unique opportunity to tap into a market that’s still in its early but explosive growth phase.

As the pharmaceutical industry evolves to meet the increasing demand for innovative therapies, one of the most exciting and lesser-known frontiers is marine